ACR Convergence Replay Webinar: Controversies in the Treatment of ANCA-Associated Vasculitis
About the Event
Date:April 15, 2025 | 7:00–8:15 PM ET
Location:Virtual
Credit:CME: 1.25
On Demand:To Be Announced
The ACR Convergence Replay 2024 webinar series will include recorded sessions from ACR Convergence followed by a live Q&A with the presenters to answer your questions and provide further insights.
This session is about the latest advancements and challenges in the management of ANCA-associated vasculitis (AAV). Although treatment guidelines have become available, many questions persist about their specific application to different clinical scenarios and patient population with ANCA-associated vasculitis (AAV). In addition, recent evidence has reopened the debate about low versus standard dose glucocorticoids. An ongoing controversy about the use of plasmapheresis persists despite the findings of the PEXIVAS study. The use of avacopan has opened an opportunity for glucocorticoid minimization and remaining indications for cyclophosphamide are important to discuss.
Target Audience
Rheumatologists, physicians, healthcare providers who care for patients with rheumatic diseases, and those interested or engaged in rheumatology research.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Review general and specific applications of the American College of Rheumatology/Vasculitis Foundation treatment guidelines for GPA and MPA
- Discuss recent data regarding use of low versus standard dose glucocorticoids in AAV
- Discuss and review applications for avacopan in AAV
- Discuss and review current indications for plasmapheresis in AAV
ACR Convergence 2024 All Access Attendees:
Register for Free
If you attended ACR Convergence 2024 (All Access pass) and missed a session or didn’t ask the presenter a question, don’t worry – we've got you covered. You can register for the ACR Convergence 2024 Replay event for free.
Spots are limited, so please complete the form below to request access. We will send an exclusive link to register two weeks before the event.
Note: On-demand access will be available for registered attendees. On-demand access will also be available for purchase to non-registrants within 30 days of the live program.
Program Schedule & Syllabi
Registered attendees can access the syllabi during the meeting and until 11:59 PM ET on December 31, 2025. To access syllabi, login and go to My Learning.
Registration Fees
Registration is open until April 14 at 5:00 PM ET.
ACR Member: $99
ARP Member: $79
Potential ACR/ARP Member: $149
Registration Guidelines
Full payment is due at the time of registration. Registration closes April 14 at 5:00 PM ET.
Cancellations and Refund Requests
- Cancellations and refund requests must be received in writing by April 7, at education@rheumatology.org. Refunds will not be provided for cancellations received after the cancellation deadline.
- A cancellation fee of $50 will be deducted.
- Refund requests received will be processed within 2–3 weeks of receipt.
- No-shows will not receive a refund.
- Cancelled registrations are nontransferable.
Corporate Support
The American College of Rheumatology thanks our corporate supporters and partners for their commitment to advancing rheumatology by supporting ACR and ARP programs and initiatives.
See current supporters, guidelines, and benefits of supporting the ACR.
This activity is not eligible for MOC.
CME
Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
See the ACR’s CME Mission Statement. For more information, download the AMA PRA Booklet.
Designation Statement
The American College of Rheumatology designates this Virtual Activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME credit must be claimed by December 31, 2025, at 11:59 PM ET.
Instructions to Claim CME Credit
Credit claiming is available after the activity starts.
The deadline to claim CME credit for ACR Convergence Replay Webinar: Controversies in the Treatment of ANCA-Associated Vasculitis is December 31, 2025.
- Log in to the My Credit page.
- Locate ACR Convergence Replay Webinar: Controversies in the Treatment of ANCA-Associated Vasculitis and click Claim Credit. Enter the amount of credit commensurate with your participation. (To view or update your credit, select View Credit.)
Certificates
After claiming credit, you can access and print certificates in the ACR Learning Center on the My Learning page.
ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.
Nature of Financial Relationships
All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:
- Advisor or review panel member
- Consultant
- Employee
- Officer or Board Member
- Grant/research support
- Speaker/honoraria includes speakers bureau, symposia, and expert witness
- Independent contractor
- Executive role and/or ownership interest
- Royalties and/or patient beneficiary
- Intellectual property/patents
- Stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Private investigator
- Expert witness
- Equity interest
- Other: specify details
None: Has no relevant financial relationship(s) with ineligible companies to disclose.
*All of the relevant financial relationships listed for these individuals have been mitigated.
ACR Convergence Replay Webinar: Controversies in the Treatment of ANCA-Associated Vasculitis Disclosures (coming soon)